From the 1/2yr report.... "Large pharmaceutical companies are interested in the SSAO enzyme for its role in various inflammatory diseases such as non-alcoholic steatohepatitis (NASH) and chronic obstructive pulmonary disease (COPD). Term sheets have been received and the Company is currently at the contract negotiation stage."
....Contract negotiation stage..... wont be far off a further announcement.
- Forums
- ASX - By Stock
- SNT
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-6
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
3.3¢ |
Change
0.001(3.13%) |
Mkt cap ! $42.58M |
Open | High | Low | Value | Volume |
3.1¢ | 3.4¢ | 3.1¢ | $77.05K | 2.374M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 351201 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 673566 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 351201 | 0.033 |
3 | 520000 | 0.032 |
2 | 247700 | 0.031 |
4 | 1143175 | 0.030 |
7 | 1377931 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 673566 | 1 |
0.035 | 200000 | 1 |
0.036 | 343537 | 2 |
0.039 | 16000 | 1 |
0.040 | 200565 | 2 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |